Madrigal Pharmaceuticals, Inc. Stock Chart

Madrigal Pharmaceuticals, Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Madrigal Pharmaceuticals, Inc.

LSE
Market Cap
$9.87B
Shares Out.
22.29M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

www.madrigalpharma.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0JXI.GB (0JXI.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart